tert-Butyl 4-(pyrimidin-4-yl)-3,6-dihydropyridine-1(2H)-carboxylate

Catalog No. :
ACSEOQ102
CAS No. :
2682114-28-7
Molecular Formula :
C14H19N3O2
Molecular Weight :
261.33

IUPAC Name:tert-butyl 4-(pyrimidin-4-yl)-3,6-dihydropyridine-1(2H)-carboxylate

tert-Butyl 4-(pyrimidin-4-yl)-3,6-dihydropyridine-1(2H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$71.00Login to see priceInquiryInquiry
250mg97%$94.00Login to see priceInquiryInquiry
1g97%$252.00Login to see priceInquiryInquiry
5g97%$915.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(pyrimidin-4-yl)-3,6-dihydropyridine-1(2H)-carboxylate
IUPAC Nametert-butyl 4-(pyrimidin-4-yl)-3,6-dihydropyridine-1(2H)-carboxylate
Molecular FormulaC14H19N3O2
Molecular Weight261.33
SMILESCC(C)(C)OC(=O)N1CC=C(C2=NC=NC=C2)CC1
InChI KeyIOPNMMXSEQBYGN-UHFFFAOYSA-N
Synonym1(2H)-Pyridinecarboxylic acid, 3,6-dihydro-4-(4-pyrimidinyl)-, 1,1-dimethylethyl ester
CAS No.2682114-28-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACSEOQ102 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZAUP421 route compound structure diagram
    ACZAUP421286961-14-6 In Stock
  2. Plus
  3. ACYSVW096 route compound structure diagram
    ACYSVW096179051-78-6 In Stock
  4. Then
  5. ACSEOQ102 route product structure diagram
    ACSEOQ1022682114-28-7
Inquiry

2. ACSEOQ102 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDLFS210 route compound structure diagram
    ACDLFS2101187931-22-1 In Stock
  2. Plus
  3. ACWFBU375 route compound structure diagram
    ACWFBU375844501-00-4 In Stock
  4. Then
  5. ACSEOQ102 route product structure diagram
    ACSEOQ1022682114-28-7
Inquiry

Comments (0)